Compare LAES & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAES | TLRY |
|---|---|---|
| Founded | 2022 | N/A |
| Country | Switzerland | Canada |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 675.0M | 570.4M |
| IPO Year | 2022 | 2018 |
| Metric | LAES | TLRY |
|---|---|---|
| Price | $2.51 | $4.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $4.00 | ★ $72.33 |
| AVG Volume (30 Days) | ★ 14.2M | 4.4M |
| Earning Date | 03-31-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $93.36 | $8.79 |
| Revenue Next Year | $43.06 | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.99 | $0.60 |
| 52 Week High | $8.71 | $15.70 |
| Indicator | LAES | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 42.77 | 61.69 |
| Support Level | $2.35 | $4.20 |
| Resistance Level | $3.40 | $4.85 |
| Average True Range (ATR) | 0.15 | 0.22 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 48.28 | 85.83 |
SEALSQ Corp develops certified secure microcontrollers and implements post-quantum cryptography. The company develops solutions including post-quantum microchips and devices that can be used in a variety of applications, from multi-factor authentication, home automation, and IT network infrastructure to automotive, industrial automation, and control systems. The company's vaultIC range offers a set of ready-to-use secure elements designed to implement embedded security for any kind of device with fast time-to-market and high flexibility. The company's products include VaultIC155, VaultIV18x, VaultIC292, and VaultIC40x. The company generates a majority of its revenue from North America, while it also has its presence in Europe, Middle East & Africa, Asia Pacific, and Latin America.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.